Literature DB >> 32485577

Mesothelial cells regulate immune responses in health and disease: role for immunotherapy in malignant mesothelioma.

Steven E Mutsaers1, Fiona J Pixley2, Cecilia M Prêle3, Gerard F Hoyne4.   

Abstract

The mesothelium when first described was thought to function purely as a non-adhesive surface to facilitate intracoelomic movement of organs. However, the mesothelium is now recognized as a dynamic cellular membrane with many important functions that maintain serosal integrity and homeostasis. For example, mesothelial cells interact with and help regulate the body's inflammatory and immune system following infection, injury, or malignancy. With recent advances in our understanding of checkpoint molecules and the advent of novel immunotherapy approaches, there has been an increase in the number of studies examining mesothelial and immune cell interaction, in particular the role of these interactions in malignant mesothelioma. This review will highlight some of the recent advances in our understanding of how mesothelial cells help regulate serosal immunity and how in a malignant environment, the immune system is hijacked to stimulate tumor growth. Ways to treat mesothelioma using immunotherapy approaches will also be discussed.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32485577     DOI: 10.1016/j.coi.2020.04.005

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  2 in total

1.  Editorial: Novel agents and combinations for treatment of malignant pleural mesothelioma in pre-clinical models.

Authors:  Sze-Kwan Lam; Steven Eugene Mutsaers
Journal:  Front Pharmacol       Date:  2022-09-06       Impact factor: 5.988

2.  Activation of DNA Damage Tolerance Pathways May Improve Immunotherapy of Mesothelioma.

Authors:  Hélène Brossel; Alexis Fontaine; Clotilde Hoyos; Majeed Jamakhani; Mégane Willems; Malik Hamaidia; Luc Willems
Journal:  Cancers (Basel)       Date:  2021-06-27       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.